Regeneron (REGN) COVID-19 Antibody Cocktail Prevented 100% of Symptomatic Infections When Used as Passive Vaccine
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 4/19/2024
- Futures drop as Middle East tensions simmer, Netflix slumps
- Sony/Apollo bid for Paramount could be worth as much as $29 billion - Source
- Netflix Q1 earnings top estimates on blowout subscriber growth
- Stocks off two-month low as fear of Middle East escalation eases
- Gold prices rally past $2,400 on reports of Israel strikes on Iran
- Tritium DCFC Limited (DCFC): Three Australian subsidiaries were determined to be insolvent or likely to become insolvent
- Hasbro (HAS) Announces Resignation of Cynthia Williams, President of Wizards of the Coast and Hasbro Gaming
- Frontier Communications (FYBR) says third party had gained unauthorized access to portions of its information technology environment
- Ibotta (IBTA) Prices 6.56M Share IPO at $88/sh
- Netflix (NFLX) Tops Q1 EPS by 77c, Offers Guidance
- Netflix, Tesla, Amex, P&G fall premarket; Paramount Global gains
- After-hours movers: Netflix, Intuitive Surgical, Nordstrom, KB Home
- Midday movers: Tesla, Blackstone, Las Vegas Sands fall; DR Horton rises
- After-hours movers: Alcoa rises; Equifax and Las Vegas Sands fall
- Midday movers: Travelers, JB Hunt fall; United Airlines rises
Regeneron Reports Positive Interim Data with REGEN-COV™ Antibody Cocktail used as Passive Vaccine to Prevent COVID-19
January 26, 2021 7:00 AM ESTTARRYTOWN, N.Y., Jan. 26, 2021 /PRNewswire/ --
Reduction in overall infections seen within first week, with 100% prevention of symptomatic infections
Markedly decreased levels and duration of viral shedding in asymptomatic infections that still occurred in REGEN-COV group
Confirmatory Phase 3 results expected early in second quarter
Potential application in people who need immediate protection or respond poorly to vaccination
REGEN-COV 1,200 mg administered by subcutaneous injection, providing greater convenience and efficiency than infusion
Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced positive... More
